CARYSIL Intrinsic Value
CARYSIL intrinsic value. CARYSIL (CARYSIL) median intrinsic value is ₹2062.00 from 10 valuation models (range ₹309–₹2558), vs current price ₹1031.00 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Compare with CARYSIL DCF valuation to assess whether the stock is under or overvalued.
CARYSIL Valuation Methods Summary — DCF, Graham Number & P/E
CARYSIL intrinsic value across 10 models vs current price ₹1031.00 — upside/downside and value range per method. For current market price and key ratios, visit CARYSIL share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹952.00 | ₹761.60 - ₹1142.40 | -7.7% | EPS: ₹38.08, Sector P/E: 25x |
| Book Value Method | asset | ₹2558.33 | ₹2302.50 - ₹2814.16 | +148.1% | Book Value/Share: ₹1023.33, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹2062.00 | ₹1855.80 - ₹2268.20 | +100.0% | Revenue/Share: ₹1586.67, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹2062.00 | ₹1855.80 - ₹2268.20 | +100.0% | EBITDA: ₹200.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹2467.64 | ₹1974.11 - ₹2961.17 | +139.3% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹309.30 | ₹278.37 - ₹340.23 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹706.00 | ₹635.40 - ₹776.60 | -31.5% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹2062.00 | ₹1855.80 - ₹2268.20 | +100.0% | ROE: 17.6%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹936.37 | ₹842.73 - ₹1030.01 | -9.2% | EPS: ₹38.08, BVPS: ₹1023.33 |
| Dividend Yield Method | dividend | ₹309.30 | ₹278.37 - ₹340.23 | -70.0% | DPS: ₹3.00, Target Yield: 3.0% |
CARYSIL Intrinsic Value vs Market Price — All Valuation Models
CARYSIL fair value range ₹309–₹2558 vs current market price ₹1031.00 across 10 valuation models. Read CARYSIL dividend payments for the complete payout history and dividend yield track record.
CARYSIL Intrinsic Value Analysis — Undervalued or Overvalued?
CARYSIL median intrinsic value ₹2062.00, current price ₹1031.00 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of CARYSIL?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of CARYSIL (CARYSIL) is ₹2062.00 (median value). With the current market price of ₹1031.00, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹309.30 to ₹2558.33, indicating ₹309.30 - ₹2558.33.
Is CARYSIL undervalued or overvalued?
Based on our multi-method analysis, CARYSIL (CARYSIL) appears to be trading below calculated value by approximately 100.0%.
CARYSIL Financial Health — Key Ratios vs Industry Benchmarks
CARYSIL financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.89 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 17.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.91x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CARYSIL Cash Flow Quality — Operating & Free Cash Flow
CARYSIL operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹109 Cr | ₹65 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹60 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹53 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹71 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹52 Cr | ₹16 Cr | Positive Free Cash Flow | 7/10 |